Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: A post hoc analysis of the EXCEL trial

Daniel J.F.M. Thuijs, Robert H. Habib, Stuart J. Head, John D. Puskas, David P. Taggart, Gregg W. Stone, Zixuan Zhang, Patrick W. Serruys, Joseph F. Sabik, A. Pieter Kappetein

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Aims: Accurate risk prediction in patients undergoing revascularisation is essential. We aimed to assess the predictive performance of Society of Thoracic Surgeons (STS) risk models in patients with left main coronary artery disease (LMCAD) undergoing coronary artery bypass grafting (CABG) or percutaneous coronary intervention with everolimus-eluting stents (PCI-EES). Methods and results: The predictive performance of STS risk models for perioperative mortality, stroke and renal failure was evaluated for their discriminative ability (C statistic) and calibration (Hosmer-Lemeshow goodness-of-fit-test; χ2 and p-values) among patients with LMCAD undergoing PCI-EES (n=935) and CABG (n=923) from the randomised EXCEL trial. STS risk scores, in CABG patients, showed good discrimination for 30-day mortality and average discrimination for stroke (C statistic 0.730 and 0.629, respectively) with average calibration. For PCI, STS risk scores had no discrimination for mortality (C statistic 0.507), yet good discrimination (C statistic 0.751) and calibration for stroke. The predictive performance for renal failure was good for CABG (C statistic 0.82), yet poor for PCI (C statistic 0.59). Conclusions: In selected patients with LMCAD from the EXCEL trial, STS risk models showed good predictive performance for CABG yet lacked predictive performance for PCI for perioperative mortality and renal failure. The STS stroke risk model was surprisingly more discriminating in PCI compared to CABG. Improved and procedure-specific risk prediction instruments are needed to accurately estimate adverse events after LMCAD revascularisation by CABG and PCI.

Original languageEnglish
Pages (from-to)36-43
Number of pages8
JournalEuroIntervention
Volume16
Issue number1
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • Clinical trials
  • Death
  • Drug-eluting stent
  • Revascularisation
  • Risk stratification
  • Stroke

Fingerprint

Dive into the research topics of 'Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: A post hoc analysis of the EXCEL trial'. Together they form a unique fingerprint.

Cite this